Response to Second-Line DMARDs and to Biologics in Seropositive vs. Seronegative Patients in Early and Late RA: Results from the CATCH Cohort of Early RA and a Large Established RA Database

被引:0
|
作者
Cao, Yang [1 ]
Bonner, Ashley [2 ]
Barra, Lillian [3 ]
Thorne, Carter [4 ]
Haraoui, Boulos [5 ]
Boire, Gilles [6 ]
Hitchon, Carol [7 ]
Le Riche, Nicole [1 ]
Bell, David [1 ]
Thompson, Andrew [1 ]
Keystone, Edward [8 ]
Bykerk, Vivian [8 ]
Pope, Janet [1 ]
机构
[1] Univ Western Ontario, London, ON N6A 3K7, Canada
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] St Josephs Hlth Care, London, ON, Canada
[4] Southlake Reg Hlth Care, Arthrit Program, Newmarket, Suffolk, England
[5] Univ Montreal, Montreal, PQ, Canada
[6] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada
[7] Univ Manitoba, Winnipeg, MB, Canada
[8] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1134 / 1134
页数:1
相关论文
共 50 条
  • [41] Unmet Need in Early Rheumatoid Arthritis - Why Do Some Patients Do Badly Despite Modern Treat-to-target Strategies of Care? Results from the Scottish Early RA (SERA) Inception Cohort
    Clarke, Elizabeth
    Wood, Claire
    Tindell, Alistair
    Graham, Kay
    McIntosh, Alasdair
    Morton, Fraser
    Porter, Duncan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3474 - 3476
  • [42] Better Retention Rate of Rituximab Vs Anti-Tnf Agents As Second Line therapy in RA Patients Failing a First Anti-Tnf Agents: Results From the Rhumadata® Registry
    Choquette, D.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S859 - S859
  • [43] Unmet need in patients with early rheumatoid arthritis - why do some patients do badly despite modern treat-to-target strategies of care? Results from the Scottish Early RA (SERA) inception cohort.
    Clarke, E.
    Wood, C.
    Tindell, A.
    Graham, K.
    McIntosh, A.
    Morton, F.
    Porter, D.
    SCOTTISH MEDICAL JOURNAL, 2022, 67 (01) : 50 - 51
  • [44] MRI BONE EROSION AT BASELINE PREDICTS THE SUBSEQUENT RADIOGRAPHIC PROGRESSION IN EARLY-STAGE RA PATIENTS WHO ACHIEVED IN SUSTAINED CLINICAL GOOD RESPONSE: SUB-ANALYSIS FROM NAGASAKI UNIVERSITY EARLY ARTHRITIS COHORT
    Tamai, M.
    Arima, K.
    Nakashima, Y.
    Kita, J.
    Umeda, M.
    Fukui, S.
    Nishino, A.
    Suzuki, T.
    Horai, Y.
    Okada, A.
    Koga, T.
    Kawashiri, S. -Y.
    Iwamoto, N.
    Ichinose, K.
    Yamasaki, S.
    Nakamura, H.
    Origuchi, T.
    Aoyagi, K.
    Uetani, M.
    Eguchi, K.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 436 - 436
  • [45] MRI Bone Erosion at Baseline Predicts the Subsequent Radiographic Progression in Early-Stage RA Patients Who Achieved in Sustained Clinical Good Response: Sub-Analysis from Nagasaki University Early Arthritis Cohort
    Tamai, Mami
    Nakashima, Yoshikazu
    Arima, Kazuhiko
    Kita, Junko
    Umeda, Masataka
    Fukui, Shoichi
    Nishino, Ayako
    Suzuki, Takahisa
    Horai, Yoshiro
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Ichinose, Kunihiro
    Yamasaki, Satoshi
    Nakamura, Hideki
    Origuchi, Tomoki
    Aoyagi, Kiyoshi
    Uetani, Masataka
    Eguchi, Katsumi
    Kawakami, Atsushi
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] EARLY RA PATIENTS SEEN IN PRACTICE WHO HAVE CO-EXISTENT NON-ARTICULAR PAIN HAVE SIGNIFICANT WORSENING OF PROMIS® 29 DOMAIN SCORES. RESULTS FROM THE CATCH US STUDY
    Bykerk, V.
    Benson, C.
    Vitone, G.
    Tirpack, A.
    Bartlett, S. J.
    Bingham, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1387 - 1387
  • [47] Reduction in Structural Damage Progression and Improvement in Clinical Response with Abatacept Treatment in Patients with ACPA plus , Early RA: Results from a Post Hoc Analysis of the AVERT-2 Study by Baseline Erosion Scores
    Pachai, Chahin
    Connolly, Sean E.
    Tanaka, Yoshiya
    Bykerk, Vivian
    Huizinga, Tom
    Citera, Gustavo
    Bingham, Clifton O., III
    Du, Shuyan
    Hoexter, Godehard
    Fleischmann, Roy
    Banerjee, Subhashis
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 599 - 602
  • [48] Real-World Remission Outcomes in the First Year Following RA Diagnosis Vary Considerably with the Disease Activity Index Used and a Sizable Proportion Have Persistent Active Disease Across All Measures: Results from the Canadian Early Arthritis Cohort (CATCH)
    Schieir, Orit
    Bartlett, Susan J.
    Valois, Marie-France
    Bessette, Louis
    Boire, Gilles
    Hazlewood, Glen
    Hitchon, Carol
    Keystone, Edward
    Pope, Janet
    Thorne, Carter
    Tin, Diane
    Bykerk, Vivian
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] CLINICAL OUTCOMES AT WEEK 104 AND ANALYSIS OF ASSOCIATED BASELINE FACTORS AFTER AN INITIAL 1 YEAR OF CERTOLIZUMAB PEGOL AND MTX TREATMENT IN MTX-NAIVE PATIENTS WITH EARLY RA: RESULTS FROM THE SECOND YEAR OF THE C-OPERA STUDY
    Atsumi, T.
    Yamamoto, K.
    Takeuchi, T.
    Yamanaka, H.
    Ishiguro, N.
    Tanaka, Y.
    Eguchi, K.
    Watanabe, A.
    Origasa, H.
    Shoji, T.
    Togo, O.
    Okada, T.
    van der Heijde, D.
    Miyasaka, N.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 239 - 239
  • [50] One-Sixth of Canadian Newly Diagnosed RA Patients Treated in Routine Care Reported Sub-optimal Adherence to Early DMARD Strategies Associated With Poorer Disease Control at 12-Months Follow-Up: Results From the Canadian Early Arthritis Cohort Study
    Jiang, Yuxuan
    Schieir, Orit
    Valois, Marie-France
    Bartlett, Susan
    Bessette, Louis
    Boire, Gilles
    Hazlewood, Glen
    Hitchon, Carol
    Keystone, Edward
    Tin, Diane
    Thorne, Carter
    Bykerk, Vivian
    Pope, Janet
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 51 - 52